{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?min-ddpCreated.=2017-07-04T21%3A36%3A09.044Z&uin=HL465", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?min-ddpCreated.=2017-07-04T21%3A36%3A09.044Z&uin=HL465", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?min-ddpCreated.=2017-07-04T21%3A36%3A09.044Z&uin=HL465&_metadata=all", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&min-ddpCreated.=2017-07-04T21%3A36%3A09.044Z&uin=HL465", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?min-ddpCreated.=2017-07-04T21%3A36%3A09.044Z&uin=HL465", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?min-ddpCreated.=2017-07-04T21%3A36%3A09.044Z&uin=HL465", "items" : [{"_about" : "http://data.parliament.uk/resources/1672038", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1672038/answer", "answerText" : {"_value" : "
The partial suspension will remain in place until the company instigates measures to ensure the manufacturing error cannot not re-occur and we continue to monitor the company\u2019s progress. The Medicines and Healthcare products Regulatory Agency has not been informed that the regulatory action has had any deleterious impact on patients receiving their medicines.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"} } , "answeringMemberPrinted" : {"_value" : "Lord Markham"} , "dateOfAnswer" : {"_value" : "2023-11-28", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-11-28T14:54:23.52Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-11-21", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Sciensus: Licensing"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government what assessment they have made of the impact of the partial suspension of Sciensus's manufacturing licence.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2024", "label" : {"_value" : "Biography information for Lord Hunt of Kings Heath"} } , "tablingMemberPrinted" : [{"_value" : "Lord Hunt of Kings Heath"} ], "uin" : "HL465"} , {"_about" : "http://data.parliament.uk/resources/1464835", "AnsweringBody" : [{"_value" : "Ministry of Defence"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1464835/answer", "answerText" : {"_value" : "
The replacement medical capability for RFA ARGUS is being considered in the scope of the Multi Role Support Ship (MRSS) which is due to enter Service in the early 2030s.<\/p>
Regarding the replacement for HMS SCOTT, the new Multi Role Ocean Surveillance (MROS) programme is in its concept and assessment phase. Options for the procurement strategy and the project schedule are under development, but no firm decisions have yet been made.<\/p>
The National Shipbuilding Office will seek to maximise the opportunity for UK Industry within both of these programmes, within the boundaries of our international and legal obligations.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4306", "label" : {"_value" : "Biography information for Baroness Goldie"} } , "answeringMemberPrinted" : {"_value" : "Baroness Goldie"} , "dateOfAnswer" : {"_value" : "2022-06-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2022-06-08T16:23:06.483Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "11"} , "answeringDeptShortName" : {"_value" : "Defence"} , "answeringDeptSortName" : {"_value" : "Defence"} , "date" : {"_value" : "2022-05-23", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Navy and Royal Fleet Auxiliary: Shipbuilding"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government whether replacements for (1) RFA Argus, and (2) HMS Scott, will be built in UK shipyards.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3834", "label" : {"_value" : "Biography information for Lord West of Spithead"} } , "tablingMemberPrinted" : [{"_value" : "Lord West of Spithead"} ], "uin" : "HL465"} , {"_about" : "http://data.parliament.uk/resources/1327242", "AnsweringBody" : [{"_value" : "Ministry of Justice"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1327242/answer", "answerText" : {"_value" : "
The (1) total number and (2) proportion of life sentence prisoners currently in custody, who have an up to date Offender Assessment System (OASys) assessment, is shown in the following table:<\/p>
Number of life sentence prisoners currently in Custody<\/p><\/td> | Number with an OASys record able to be matched<\/p><\/td> | Number of those identified within OASys with an up to date assessment<\/p><\/td> | Percentage of those identified within OASys with an up to date assessment<\/p><\/td><\/tr> |
7542<\/p><\/td> | 7464<\/p><\/td> | 6550<\/p><\/td> | 88%<\/p><\/td><\/tr><\/tbody><\/table> <\/p> Notes for all tables:<\/p>
|